Experimental prediction of the evolution of ceftazidime resistance in the CTX-M-2 extended-spectrum beta-lactamase.

Antimicrob Agents Chemother

Department of Epidemiology, Rollins School of Public Health, Emory University, 1518 Clifton Rd., Atlanta, GA 30322, USA.

Published: March 2005

We applied in vitro evolution to an Escherichia coli strain containing bla(CTX-M-2) and obtained 10 independent mutant bla(CTX-M-2) alleles that confer elevated resistance to ceftazidime (MIC > or = 32 microg/ml) but lost the ability to confer resistance to cefepime. All alleles had a Pro-to-Ser substitution at position 167.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC549256PMC
http://dx.doi.org/10.1128/AAC.49.3.1242-1244.2005DOI Listing

Publication Analysis

Top Keywords

experimental prediction
4
prediction evolution
4
evolution ceftazidime
4
ceftazidime resistance
4
resistance ctx-m-2
4
ctx-m-2 extended-spectrum
4
extended-spectrum beta-lactamase
4
beta-lactamase applied
4
applied vitro
4
vitro evolution
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!